2/21/2025 | BKIG | Fitch rates American Medical notes A-
|
2/21/2025 | BKIG | S&P gives A- to American Medical notes
|
2/21/2025 | BKIG | Moody's gives American Medical notes Baa1
|
2/19/2025 | BKIG | S&P ups Boston Scientific
|
2/19/2025 | BKIG | Fitch lifts Boston Scientific
|
11/20/2024 | BKIG | Moody’s views Boston Scientific, AMS positively
|
2/22/2024 | BKIG | S&P assigns American Medical notes BBB+
|
2/22/2024 | BKIG | Moody’s gives American Medical notes Baa1
|
2/22/2024 | BKIG | Fitch rates American Medical notes BBB+
|
12/7/2022 | BKCVIG | S&P upgrades Boston Scientific
|
12/6/2022 | BKCVIG | Fitch boosts Boston Scientific
|
3/16/2022 | IGLM | Boston Scientific gives early results, pricing of tender, lifts cap to $2.85 billion
|
3/16/2022 | IGLM | Boston Scientific gives early results of tender offer, lifts tender amount to $2.85 billion
|
3/3/2022 | BKCVIG | Moody's gives American Medical notes Baa1
|
3/3/2022 | BKCVIG | S&P assigns American Medical notes BBB
|
3/3/2022 | BKCVIG | Fitch gives American Medical notes BBB
|
3/2/2022 | BKCVIG | S&P turns Boston Scientific view to positive
|
3/2/2022 | IGLM | Boston Scientific tenders for up to $2.5 billion notes from 13 series
|
2/23/2022 | BKCVIG | Moody's boosts Boston Scientific
|
12/6/2021 | BKCVIG | Fitch turns Boston Scientific view to positive
|
6/24/2021 | BKIG | Boston Scientific plans some debt for Farapulse acquisition
|
5/27/2021 | BKCVIG | S&P boosts Boston Scientific
|
5/15/2020 | IG | New Issue: Boston Scientific details $1.7 billion of senior notes in two parts
|
5/14/2020 | IG | Market Commentary: Honeywell, Raytheon, Boston Scientific, Manulife, Antares price; high-grade inflows down
|
5/14/2020 | IG | New Issue: Boston Scientific prices $1.7 billion of senior notes in two tranches
|
5/14/2020 | BKIG | Fitch assigns Boston Scientific notes BBB
|
5/14/2020 | IG | Market Commentary: Morning Commentary: Honeywell, Boston Scientific, PPG, Raytheon, Bank of America on tap
|
5/14/2020 | BKIG | S&P rates Boston Scientific notes BBB-
|
5/14/2020 | BKIG | Moody’s assigns Boston Scientific notes Baa2
|
5/14/2020 | IG | Boston Scientific plans to sell fixed-rate senior notes in two parts
|
11/5/2019 | IGLM | Boston Scientific prices, posts early results of capped tender offer
|
11/5/2019 | IGLM | Boston Scientific posts early results of capped tender for four series
|
10/22/2019 | BKIG | Fitch rates Boston Scientific notes BBB
|
10/22/2019 | IGLM | Boston Scientific tenders for up to $1 billion notes from four series
|
2/25/2019 | IGLM | Boston Scientific calls 6% notes, 2.85% notes for redemption
|
2/22/2019 | IG | Market Commentary: NextEra Energy, Paccar tap primary market; strong deal volume eyed; Paccar firms; CBS flat
|
2/21/2019 | IG | Market Commentary: Boston Scientific, CSX, Weyerhaeuser, Florida Power, Sweden price; Woodside holds roadshow
|
2/21/2019 | IG | New Issue: Boston Scientific prices $4.3 billion of senior notes in five parts
|
2/21/2019 | IGLM | Boston Scientific to redeem 6% notes, 2.85% notes via new notes
|
2/21/2019 | BKIG | Moody's rates Boston Scientific notes Baa2
|
2/21/2019 | BKIG | S&P rates Boston Scientific notes BBB-
|
2/21/2019 | BKIG | Fitch rates Boston Scientific notes BBB
|
2/21/2019 | IG | Market Commentary: Morning Commentary: Boston Scientific, CSX, Weyerhaeuser, Florida Power, Sweden on tap
|
2/21/2019 | IG | Boston Scientific offers $4.3 billion fixed-rate notes in five parts
|
11/21/2018 | BKIG | S&P affirms Boston Scientific
|
11/20/2018 | BKIG | Boston Scientific plans to incur debt for £3.3 billion buyout of BTG
|
8/30/2018 | BKIG | S&P revises Boston Scientific view to positive
|
8/21/2018 | BKIG | Fitch gives Boston Scientific loan BBB
|
8/16/2018 | BKIG | Fitch affirms Boston Scientific
|
2/22/2018 | IG | Market Commentary: High-grade supply robust; BNP, Kinder Morgan, American Express, Deutsche among issuers
|
2/22/2018 | IG | New Issue: Boston Scientific prices $1 billion 4% 10-year notes at 110 bps over Treasuries
|
2/22/2018 | BKIG | Fitch gives Boston Scientific notes BBB
|
2/22/2018 | BKIG | Moody’s rates Boston Scientific notes Baa2
|
2/22/2018 | BKIG | S&P rates Boston Scientific notes BBB-
|
2/22/2018 | IG | Market Commentary: Morning Commentary: Highwoods firms deal details; American Express, Kinder Morgan on deck
|
2/22/2018 | IG | Boston Scientific plans to conduct offering of senior notes
|
7/28/2017 | BKIG | S&P: Boston Scientific view to stable
|
6/16/2017 | BKIG | Fitch ups Boston Scientific, facility, notes to BBB
|
6/13/2017 | BKIG | S&P gives Boston Scientific short-term A-3
|
12/7/2016 | BKIG | Moody’s raises Boston Scientific to Baa2
|
5/7/2015 | IG | Market Commentary: Week’s supply tops $50 billion; Boston Scientific, Chevron Phillips price; AbbVie tight
|
5/7/2015 | IG | New Issue: Boston Scientific prices $1.85 billion of notes in tranches due 2020, 2022, 2025
|
5/7/2015 | IGLM | Boston Scientific to redeem some 5.5%, 6.4% notes with note proceeds
|
5/7/2015 | BKIG | Moody’s rates Boston Scientific notes Baa3
|
5/7/2015 | BKIG | S&P rates Boston Scientific notes BBB-
|
5/7/2015 | BKIG | Fitch rates Boston Scientific notes BBB-
|
5/7/2015 | IG | Boston Scientific sets talk, to sell notes in three tranches Thursday
|
4/16/2015 | BKIG | S&P assigns BBB- to Boston Scientific loans
|
3/2/2015 | BKIG | S&P: Boston Scientific view now negative
|
2/18/2015 | BKIG | S&P affirms Boston Scientific on settlement news
|
9/11/2013 | IGLM | Boston Scientific calls entire $1.45 billion of 5.45%, 4.5% notes
|
8/12/2013 | IG | Market Commentary: Midday Commentary: Ford, Wells Fargo firm, Procter & Gamble eases
|
8/9/2013 | IG | Market Commentary: Midday Commentary: Boston Scientific five-year notes tighten; Procter & Gamble eases
|
8/8/2013 | IG | New Issue: Boston Scientific sells $1.05 billion notes in five-, 10-year tranches
|
8/8/2013 | IG | Market Commentary: Investment-grade primary sees 'surprise rush' of new deals; secondary focuses on new issues
|
8/8/2013 | BKIG | S&P rates Boston Scientific notes BBB-
|
8/8/2013 | IGLM | Boston Scientific to redeem 5.45%, 4.5% notes via offerings proceeds
|
8/8/2013 | BKIG | Moody's gives Boston Scientific notes Baa3
|
8/8/2013 | BKIG | Fitch rates Boston Scientific notes BBB-
|
8/8/2013 | IG | Boston Scientific planning two-tranche offering of senior notes
|
7/19/2012 | BKIG | Fitch affirms Boston Scientific
|
3/9/2012 | IG | Moody's: Boston Scientific unaffected
|
3/9/2012 | IG | S&P affirms Boston Scientific
|
2/13/2012 | IG | Moody's ups Boston Scientific
|
7/21/2011 | BKHYIG | Fitch lifts Boston Scientific from junk
|
1/3/2011 | IGLM | Boston Scientific redeems $600 million of 6% notes due 2011 in full
|
10/29/2010 | IG | Fitch: Boston Scientific outlook positive
|
10/29/2010 | IG | Moody's lifts Boston Scientific
|
6/23/2010 | IGLM | Boston Scientific to repay $850 million of notes with loan proceeds
|
3/16/2010 | IG | Market Commentary: First Niagara, Developers Diversified price deals, Hartford plans sale; banks trade firmer
|
3/15/2010 | IG | Market Commentary: Commonwealth Bank, EIB, Entergy price bonds; trading volume down, Boston Scientific widens
|
3/15/2010 | IG | Market Commentary: Commonwealth Bank, EIB, Entergy price bonds; trading volume down, Boston Scientific widens
|
2/1/2010 | IG | Market Commentary: Procter & Gamble sells bonds, UDR reopens notes, new deals to increase; P&G gains in secondary
|
12/11/2009 | IG | Market Commentary: TIAA prices 30-year; Boston Scientific tranches in sharply, Citigroup, Time Warner active
|
12/10/2009 | HYIG | New Issue: Boston Scientific sells $2 billion split-rated notes in three tranches
|
12/10/2009 | IG | Market Commentary: Boston Scientific, Caterpillar, American Transmission tap high-grade market; Citi tightens
|
8/3/2007 | IG | Volatile conditions continue to hamper investment grade trading at end of week with few new issues
|